LOC374920_6330408A02Rik Inhibitors
LOC374920_6330408A02Rik inhibitors encompass a collection of compounds that affect various signaling pathways and biological processes which LOC374920_6330408A02Rik may be directly involved in. Staurosporine, a broad-spectrum kinase inhibitor, can inhibit the activity of kinases that are responsible for the phosphorylation of LOC374920_6330408A02Rik, a post-translational modification crucial for many proteins' activation and function. Similarly, LY294002 and Wortmannin, both PI3K inhibitors, may reduce the activation of AKT, a kinase that could be involved in the phosphorylation and subsequent activation of LOC374920_6330408A02Rik. This suggests that PI3K signaling is integral to LOC374920_6330408A02Rik functionality, and its inhibition could lead to a decrease in LOC374920_6330408A02Rik activity.
Other inhibitors, such as Rapamycin and Bortezomib, target mTOR signaling and proteasome activity, respectively. Rapamycin's inhibition of mTOR could affect the cell growth and survival pathways, potentially decreasing the activity of proteins, including LOC374920_6330408A02Rik, that are involved in these processes. Bortezomib couldlead to the accumulation of negative regulators of LOC374920_6330408A02Rik by inhibiting the degradation of ubiquitinated proteins. The JNK pathway, targeted by SP600125, and the p38 MAPK pathway, targeted by SB203580, are critical in stress responses and cellular homeostasis. Inhibiting these pathways could prevent activation of LOC374920_6330408A02Rik if it is a stress-responsive protein. PD98059 and U0126, as MEK inhibitors, could disrupt the ERK/MAPK pathway, which might be required for the phosphorylation and activation of LOC374920_6330408A02Rik. PP2, as an Src kinase inhibitor, could decrease activation signals for LOC374920_6330408A02Rik, assuming it is downstream of Src kinase signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB 431542 is an inhibitor of the TGF-β type I receptor ALK5, which is involved in the TGF-β signaling pathway. LOC374920_6330408A02Rik may be regulated by TGF-β signaling; thus, inhibition of this pathway by SB 431542 can lead to a decrease in LOC374920_6330408A02Rik activity if it is downstream of TGF-β receptor activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can lead to the inhibition of the AKT signaling pathway. If LOC374920_6330408A02Rik is dependent on PI3K/AKT signaling for its activity, the inhibition of this pathway by LY294002 can lead to reduced activity of LOC374920_6330408A02Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, a kinase involved in the MAPK/ERK pathway. If LOC374920_6330408A02Rik functions downstream of or is regulated by the MAPK/ERK pathway, MEK inhibition by U0126 can result in decreased activity of LOC374920_6330408A02Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is another MEK inhibitor that blocks the MAPK/ERK pathway. If LOC374920_6330408A02Rik is activated by ERK signaling, PD 98059 can inhibit this pathway and thus decrease the activity of LOC374920_6330408A02Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, which reduces protein synthesis and cell proliferation. If LOC374920_6330408A02Rik is regulated by mTOR-related pathways, its activity can be inhibited by rapamycin. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin is a specific inhibitor of N-WASP, necessary for actin filament assembly. If LOC374920_6330408A02Rik is involved in cytoskeletal organization, its function can be inhibited by the disruption of actin dynamics through wiskostatin. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $510.00 | ||
YM-254890 is a specific inhibitor of Gαq protein signaling. If LOC374920_6330408A02Rik activity is Gαq-dependent, its function can be inhibited by blocking this G-protein signaling pathway with YM-254890. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go 6983 is a broad-spectrum protein kinase C (PKC) inhibitor. If LOC374920_6330408A02Rik is regulated by PKC-mediated signaling, inhibition of PKC by Go 6983 could lead to decreased LOC374920_6330408A02Rik activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK signaling pathway. Inhibition of JNK can lead to decreased activity of LOC374920_6330408A02Rik if it is regulated by JNK signaling. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is an inhibitor of myosin light chain kinase (MLCK), which is involved in muscle contraction and cytoskeletal dynamics. If LOC374920_6330408A02Rik interacts with pathways involving MLCK, inhibition of MLCK by ML-7 could lead to decreased LOC374920_6330408A02Rik activity. | ||||||